Absence of profound hyperinsulinism in polycystic ovary syndrome is associated with subtle elevations in the plasminogen activator inhibitor system

Author： Sills E. Scott Drews C. D. Perloe M. Tucker M. J. Kaplan C. R. Palermo G. D.

Publisher： Informa Healthcare

ISSN： 1473-0766

Source： Gynecological Endocrinology, Vol.17, Iss.3, 2003-06, pp. : 231-237

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Tissue plasminogen activator and plasminogen activator inhibitor 1 in obese and lean patients with polycystic ovary syndrome

By Lindholm Åsa Bixo Marie Eliasson Mats Hudecova Miriam Arnadottir Ragnheidur Holte Jan Poromaa Inger Sundström

Gynecological Endocrinology, Vol. 26, Iss. 10, 2010-10 ,pp. : 743-748

Informa Healthcare

Access to resources Recommend Favorite

Correlation between plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G polymorphism and metabolic/proinflammatory factors in polycystic ovary syndrome

By Sales MF Sóter MO Candido AL Fernandes AP Oliveira FR Ferreira ACS Sousa MO Ferreira CN Gomes KB

Gynecological Endocrinology, Vol. 29, Iss. 10, 2013-10 ,pp. : 936-939

Informa Healthcare

Access to resources Recommend Favorite

Are polycystic ovaries associated with cardiovascular disease risk as polycystic ovary syndrome?

By Engin-Üstün Yaprak Üstün Yusuf Meydanli M. Kafkasli Ayşe Yetkin Gülay

Gynecological Endocrinology, Vol. 22, Iss. 6, 2006-06 ,pp. : 324-328

Informa Healthcare

Access to resources Recommend Favorite

Hyperinsulinaemia and polycystic ovary syndrome

By Conway Gerard

Human Fertility, Vol. 3, Iss. 2, 2000-05 ,pp. : 93-95

Informa Healthcare

Access to resources Recommend Favorite

Definition of polycystic ovary syndrome

By Dewailly Didier

Human Fertility, Vol. 3, Iss. 2, 2000-05 ,pp. : 73-76

Informa Healthcare

Access to resources Recommend Favorite